Flagship-backed computational biology startup lays off 43% of staff

Vesalius Therapeutics, a computational biology startup launched by Cambridge's Flagship Pioneering only six months ago, has laid off 43% of its workforce — 29 employees, a spokeswoman confirmed.

Previous Centene Corp. reaches $165.6M settlement with Texas over pharmacy benefit practices
Next Cooper announces state grant for medical-sterilization company's plan to set up in Burlington

No Comment

Leave a reply

Your email address will not be published.